ArticleArchives of osteoporosis2026
Association between post-discharge destination and osteoporosis medication use after acute-care hospital discharge for hip fracture: a population-based cohort study.
Article in Archives of osteoporosis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From prescription claims to treatment gaps after hip fracture: methodological considerations.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Post-discharge destination was associated with differences in osteoporosis medication use after hip fracture. Discharge to long-term care facilities or home with long-term care services was associated with lower medication use. Prior treatment history was associated with differences in subgroup-specific estimates among community-dwelling patients, although formal interaction testing was not statistically significant.
backgroundPost-discharge destination may influence osteoporosis care after hip fracture, but evidence is limited.
methodsUsing the National Health Insurance Service-Senior cohort in South Korea, we identified patients aged ≥ 60 years who underwent surgical treatment for incident hip fracture between 2005 and 2017. Post-discharge destination at 30 days was categorized as home without LTC services, home with LTC services, hospital, or LTC facility. The primary outcome was any osteoporosis medication use within 1 year after discharge from an acute-care hospital, defined as at least one prescription during follow-up. Incidence rates were calculated, and adjusted hazard ratios (aHRs) were estimated using Cox proportional hazards models, with stratified analyses according to prior osteoporosis medication use.
resultsAmong 12,226 patients, osteoporosis medication use within 1 year differed significantly by post-discharge destination. Compared with patients discharged home without LTC services, those discharged to LTC facilities (aHR, 0.61; 95% CI, 0.50-0.76) and home with LTC services (aHR, 0.84; 95% CI, 0.73-0.97) were associated with a lower hazard of receiving osteoporosis medication. In stratified analyses, discharge to LTC facilities was consistently associated with lower medication use across subgroups defined by prior treatment history. Among patients discharged home with LTC services, lower medication use was observed primarily among treatment-naïve patients, whereas this pattern was less apparent among those with prior medication use; however, formal interaction testing was not statistically significant.
conclusionsOsteoporosis medication use after hip fracture was associated with differences according to post-discharge destination. Lower medication use was observed among patients discharged to LTC facilities and, to a lesser extent, among those receiving home-based LTC services. These findings should be interpreted with caution, as some of the lower use in LTC settings may reflect appropriate clinical decision-making in the context of competing care priorities or limited life expectancy.
Indexed as
Identifiers
42525173What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.